Clinical trial Recruiting at 1 site Observational Ages 5 to 21

Developing a way to measure treatment effects in children with rheumatologic conditions

Official title: Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Run by Children's National Research Institute · NCT04833465 · Data updated 2026-11-12

This study is trying to find a better way to measure how well treatments work for kids with certain rheumatologic conditions like Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus, and Fibromyalgia.

Quick facts

Study typeObservational
Ages5 Years to 21 Years
SexAll
Enrollment90 (estimated)
SponsorChildren's National Research Institute
Academic / other
Locations1 site (Washington D.C., District of Columbia)
StatusRecruiting
StartedJuly 16, 2021
Main results expectedApril 2028
Study endsDecember 2028
Registry record updatedJuly 24, 2026
Trial IDNCT04833465 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 5 and older diagnosed with Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus, or Fibromyalgia.

Probably not a fit

Patients with documented eye diseases that prevent pupillometry will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a physiologic endpoint for assessing pain and treatment effects in children with Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus, and Fibromyalgia. By collecting pilot data over one year, the study will follow patients during their standard care visits without altering their treatment. The goal is to establish a more objective method for evaluating treatment outcomes, potentially reducing the trial-and-error approach currently used. The study will include children aged 5 and older who have a documented diagnosis of one of the target conditions.

Why it matters

Potential benefit: If successful, this study could lead to more precise and effective treatment strategies for children with rheumatologic conditions.

How similar studies have gone: While similar studies have explored endpoints in rheumatologic conditions, this specific approach is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

In order to be eligible for inclusion in the study, an individual must meet all of the following criteria:

* Male or female ≥ 5 years of age at screening.
* Documentation of a JIA, SLE or FM diagnosis as evidenced by history

Exclusion Criteria:

Any individual who meets any of the following criteria will be excluded from participation in this study:

• Documented history of eye disease precluding pupillometry

Where it's running

  • Children's National Health System
    Washington D.C., District of Columbia, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.